Rival camps in Medical City dispute move to reinforce positions | Inquirer Business

Rival camps in Medical City dispute move to reinforce positions

By: - Business News Editor / @daxinq
/ 04:07 PM October 09, 2018

DR. ALFREDO Bengzon, erstwhile president and CEO of The Medical City (TMC).

The controversy surrounding ownership of The Medical City (TMC) continued on Tuesday with the warring sides moving to fortify their legal positions in the battle for control of the health institution.

In a press statement, the side of its erstwhile president and CEO Alfredo Bengzon said corporate regulators are now investigating a loan agreement entered into by Clermont, a Singapore-based holdings group and a director Professional Services Inc., the hospital’s operator.

Article continues after this advertisement

According to Bengzon’s camp, the Securities and Exchange Commission (SEC) has formed a special hearing panel, represented by its Enforcement and Investor Protection, Market Securities and Research, and Corporate Governance and Finance Departments, with the mandate to “resolve the rightful ownership of shares of Professional Services Inc.”

FEATURED STORIES

Meanwhile, the camp of new hospital chair Jose Xavier Gonzales said it scored a legal victory after a court ruled that there is “no dispute that a special stockholders meeting took place on September 13, 2018, where members of the board of directors were elected by a majority of the stockholders.”

As such, they said, the court ruled that the new board and management should stay in place at The Medical City as they “appear to have a clear and unmistakable right that is entitled to protection.”

Article continues after this advertisement

“This is a clear victory for TMC stockholders, who have struggled to protect their rights against a former CEO who ignored the pleas of the majority of stockholders asking for better governance and more respect for shareholder rights,” Gonzales said.

Article continues after this advertisement

Bengzon’s camp said that the SEC’s probe of the loan transaction is key to determining whether or not the shares of the block identified with the Clermont conglomerate were validly and legally acquired.

Article continues after this advertisement

The probe stemmed from the petition filed by Bengzon who said the $38-million loan was given by the Singaporean firm to Gonzales supposedly under questionable and improper terms.

Bengzon had earlier called on Gonzales “to bare the truth” regarding the “real intention” of the loan from Viva Holdings, saying the transaction may have “failed to protect the interest of the company”. Viva Holdings is part of the Clermont Group, an international finance services and retail conglomerate.

Article continues after this advertisement

At present, the hospital is under the physical control of Gonzales’ camp, who said the courtroom victory also gives momentum to a continuing series of reforms now being undertaken at TMC.

“There’s a sense of freedom in the air, and the previous atmosphere of fear has been lifted,” said newly appointed CEO Dr. Eugenio Ramos. “More people are speaking up and contributing ideas on how we can improve, and that is the kind of collaboration that we are all hoping for.”  /kga

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Alfredo Bengzon, Business, business news, court, health institution, hospital, legal, local news, Medical City, News, Philippine news updates, Professional Services Inc., SEC, suit

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.